Hiram Leong Fong And Ellyn Lo Fong
Wailuku, Hawaii
BHealth Score
59B
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Above Average
💰
-$38K
Total Revenue
📊
$5K
Total Expenses
🏦
$114K
Net Assets
📋
$1
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
+12.8%
Year-over-year change (2022 → 2023)
Net Margin
+112.3%
Revenue minus expenses as % of revenue
Working Capital Ratio
24.64
Net assets divided by total expenses
Liabilities-to-Assets
0.0%
Total liabilities as % of total assets
Filing History
10 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | -$37,573↑13% | $4,618↑9% | $113,782↓29% | |
| 2022 | -$43,070↓871% | $4,226↓38% | $161,074 | — |
| 2021 | $5,589↓46% | $6,844↑55% | $161,074↑32% | — |
| 2020 | $10,415↑49% | $4,418↓31% | $121,607↑10% | — |
| 2019 | $6,968↑68% | $6,365↓15% | $111,030↑2% | — |
| 2015 | $4,151↓2% | $7,514↑54% | $109,211↓4% | — |
| 2014 | $4,257↓16% | $4,873↓6% | $113,546↑11% | — |
| 2013 | $5,060↑19% | $5,159↓53% | $102,190↓15% | — |
| 2012 | $4,269↓44% | $10,885↑38% | $120,601↓20% | — |
| 2011 | $7,620 | $7,862 | $151,168 | — |
Frequently Asked Questions
What does Hiram Leong Fong And Ellyn Lo Fong do?▼
Hiram Leong Fong And Ellyn Lo Fong is a unclassified nonprofit organization based in Hawaii. It is classified under NTEE code Z and is registered as a 501(c) tax-exempt organization with the IRS.
Is Hiram Leong Fong And Ellyn Lo Fong financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Hiram Leong Fong And Ellyn Lo Fong.
How much revenue does Hiram Leong Fong And Ellyn Lo Fong generate?▼
Revenue data for Hiram Leong Fong And Ellyn Lo Fong is sourced from IRS filings. Detailed financial breakdowns may be available on the organization's Form 990.
Similar Organizations
Explore more organizations in the Unclassified category, or browse all nonprofits in Hawaii.